Skip to main content

Currently Skimming:

Appendix D: Forum Member Biographies
Pages 285-306

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 285...
... He completed his residency in internal medicine and a clinical fellowship in infectious diseases at Massachusetts General Hospital, Boston, after which he moved to Stanford for a postdoctoral fellowship in 1986 and joined the faculty there in 1994. His research focus is on understanding the structure and role of the human indigenous microbial communities in health and disease.
From page 286...
... in 2001, the Senior Scholar Award in Global Infectious Diseases from the Ellison Medical Foundation in 2002, an NIH Director's Pioneer Award in 2006, and a Doris Duke Distinguished Clinical Scientist Award in 2006. He is also a fellow of the American Academy of Microbiology. Margaret A
From page 287...
... Public Health Service. In 2001 she came to her current position at Emory University, directing a center focused on emerging infectious diseases and other urgent threats to health, including terrorism.
From page 288...
... Since 2004 he has been chief executive officer of Centaur Science Group, which provides consulting services in biodefense. His main commitment is to the Defense Threat Reduction Agency's Biological Weapons Proliferation Prevention Program in Europe, the Caucasus, and Central Asia.
From page 289...
... patents and has published over 30 peer-reviewed scientific papers, particularly on the oxazolidinones and novel azetidinones. An internationally recognized drug discoverer with over 20 invited speaker presentations, he has been a member of the IOM Forum on Microbial Threats since 1997 and is on the Editorial Advisory Board of Current Pharmaceutical Design and the Faculty of 1000 Biology. In February 2009, he established SJ Brickner Consulting, LLC, which primarily offers consulting services on all aspects of medicinal chemistry and drug design related to the discovery and development of new antibiotics.
From page 290...
... Currently she is a member of the Executive Committee of the Board of Visitors of Columbia University School of Medicine, the Board of Directors of the Burroughs Wellcome Fund, and the Advisory C ­ ouncil of the School of Nursing of Johns Hopkins. Mark Feinberg, M.D., Ph.D., is vice president for medical affairs and policy in global vaccine and infectious diseases at Merck & Co., Inc., and is responsible for global efforts to implement vaccines to achieve the greatest health benefits, including efforts to expand access to new vaccines in the developing world.
From page 291...
... From 1995 to 1997, Dr. Feinberg was a medical officer in the Office of AIDS Research in the Office of the Director of the NIH, the chair of the NIH Coordinating Committee on AIDS Etiology and Pathogenesis Research, and an attending physician at the NIH Clinical Center.
From page 292...
... Captain Galloway began his Navy career at the Naval Medical Research Institute in Bethesda, Maryland, where he served as a research scientist working on vaccine development from 1980 to 1984. In late 1984, Captain Galloway left active service to pursue an academic appointment at Ohio State University, where he is now a tenured faculty member in the Department of Microbiology.
From page 293...
... He is editor of the book Tick Borne Diseases of Humans published by ASM Press in 2005, and is a staff physician and infectious diseases consultant at the NIH Clinical Center and the National Naval Medical Center-Walter Reed Army Medical Center, as well as adjunct professor of medicine at the University of Minnesota. He is active in a wide variety of clinical, public health, and product development issues, including pandemic and emerging infectious disease threats; bioterrorism preparedness and response; and blood, tissue, and vaccine safety and availability.
From page 294...
... Recent honors and awards include being named an honorary member of the American Society of Tropical Medicine and Hygiene in 2002, an associate member of the National Academy of Medicine in 2002, an honorary member of the Society of Internal Medicine in 2000, and a distinguished visitor at the Faculty of Medical Sciences, University of Cordoba, Argentina, in 1999. In 1988 he received the Golden Medal for Outstanding Contribution in the Field of Infectious Diseases awarded by Trnava University, Slovakia.
From page 295...
... and continued at the NCI as a senior staff fellow in molecular oncology. She moved into health science administration in 1986, focusing on respiratory pathogens, particularly vaccine development.
From page 296...
... of CDC. He is a member of the IOM; and has been awarded the 2004 Award for Excellence of American Public Health Association, the 2005 Donald Mackay Award from the American Society for Tropical Medicine and Hygiene, and the 2007 Heinz Award on the Human Condition.
From page 297...
... Hughes worked initially on foodborne and waterborne diseases and subsequently on infection control in health-care settings. He served as director of CDC's Hospital Infections Program from 1983 to 1988, as deputy director of NCID from 1988 to 1992, and as director of NCID from 1992 to 2005. A major focus of Dr. Hughes' career has been on building partnerships among the clinical, research, public health, and veterinary communities to prevent and respond to infectious diseases at the national and global levels. His research interests include emerging and reemerging infectious diseases; antimicrobial resistance; foodborne diseases; health-care-associated infections; vectorborne and zoonotic diseases; rapid detection of and response to infectious diseases and bioterrorism; strengthening public health capacity at the local, national, and global levels; and prevention of waterrelated diseases in the developing world. Dr.
From page 298...
... In 1986 he integrated the clinical infectious diseases program into the Division of Geographic Medicine and Infectious Diseases, continuing as division chief until 1998. He has worked in the laboratory and in the field in Latin America, Africa, and Asia on basic and clinical infectious diseases and HIV/AIDS research.
From page 299...
... As dean and professor of large animal clinical sciences, Dr. King was instrumental in obtaining funds for construction of the $60 million Diagnostic Center for Population and Animal Health, initiated the Center for Emerging Infectious Diseases in the college, served as the campus leader in food safety, and had oversight for the National Food Safety and Toxicology Center.
From page 300...
... Dr. King is one of the developers of the Science, Politics, and Animal Health Policy Fellowship Program, and he lectures extensively on the future of animal health, emerging zoonoses, and veterinary medicine.
From page 301...
... He is past chair of the NCID-CDC Board of Scientific Counselors and currently serves as a member of the U.S. Delegation to the U.S.–Japan Cooperative Medical Sciences Program. He was cochair of the NAS Committee on Advances in Technology and the Prevention of Their Application to Next Generation Biowarfare Threats, and he recently chaired an IOM study committee related to vaccines for the protection of the military against naturally occurring infectious disease threats.
From page 302...
... He has served as a member of the IOM‑NAS Committee on Emerging Microbial Threats to Health, chaired its Task Force on Viruses, and was a contributor to the resulting report Emerging Infections (1992)
From page 303...
... He has also served on the IOM Committee to Ensure Safe Food from Production to Consumption, and on the IOM Committee on the Department of Defense Persian Gulf Syndrome Comprehensive Clinical Evaluation Program, and as a reviewer for the IOM report Chemical and Biological Terrorism: Research and Development to Improve Civilian Medical Response. George Poste, Ph.D., D.V.M., is director of the Biodesign Institute and Del E
From page 304...
... He served his residency at the Northwestern University School of Medicine and his infectious diseases fellowship at the University of Cincinnati School of Medicine. He is program director for infectious diseases for the Department of Veterans Affairs Central Office in Washington, DC, as well as the chief of the medical service at the Cincinnati VA Medical ­Center.
From page 305...
... He was president of the Infectious Diseases Society of America from 1996 to 1997. He was also a member of the IOM Committee on Microbial Threats to Health (1990-1992)
From page 306...
... Currently, Dr. Trostle leads the USAID Infectious Disease Surveillance Initiative as well as the Avian Influenza Unit.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.